Insufficient lipid lowering therapy could not bring favorable prognostic effect in high risk patients who were functionally deferred percutaneous coronary intervention
The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.
Event:
ESC Congress 2018
Topic:
Aldosterone Antagonists
Session:
Cardiovascular drug therapy in special populations
Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure.
Event:
ESC Congress 2018
Topic:
Heart Failure with Reduced Ejection Fraction (HFrEF)
Session:
Strategies to optimize established heart failure therapies